Results 141 to 150 of about 197,062 (266)

Hepatitis C Antibody [PDF]

, 2020
openaire   +1 more source

Hepatitis C antibody and posttransfusion hepatitis in hemophiliacs.

Journal of the Japan Society of Blood Transfusion, 1991
Takamatsu, Junki, Kawashima, Kohei, Yamaguchi, Hiroshi, Kamiya, Tadashi, Ogata, Kanji, Saito, Hidehiko   +5 more
openaire   +2 more sources

Emerging antiviral drugs and immunotherapy for chronic hepatitis B and associated liver disease. [PDF]

Front Immunol
Zhu C, Yang J, Sheng Y, Fang M.
europepmc   +1 more source

Molecular, serological, and epidemiological characterisation of a hepatitis A virus outbreak in Maharashtra, India, 2025. [PDF]

Indian J Med Res
Tomar S, Hansraj Pise K, Ramdasi A, Hundekar S, Deoshatwar AR, Thorat N, Jawalkar P, Ayachit P, Mahesh Kulkarni P, Nagargoje BB, Vishwanath Tandale B, Shete Aich A.   +11 more
europepmc   +1 more source

Constipation With AMA and ANA Positivity as an Atypical Manifestation of Celiac Disease: A Case Report. [PDF]

Clin Case Rep
Hussain SM, Khan M, Anas Z, Khan Z, Abbasi A, Haque MA.   +5 more
europepmc   +1 more source

Platelet antibodies in viral hepatitis.

The Turkish journal of pediatrics, 1987
O Hasdal, S Ozsoylu, N Koçak
openaire   +2 more sources

Tolerability of Adjuvant Nivolumab in Esophageal or Gastroesophageal Junction Cancer: A Real‐World Study

International Journal of Cancer, EarlyView.
ABSTRACT Adjuvant nivolumab is approved for esophageal or gastroesophageal junction cancer after neoadjuvant chemoradiotherapy and resection. In the CheckMate‐577 trial, Grade 3–5 nivolumab‐related adverse events (AEs) occurred in 5% of patients, with early discontinuation due to toxicity in 9%. However, real‐world data on immunotherapy‐related adverse
Michelle Koops van ’t Jagt, Anniek Strijdhorst, Tamara Jessica Huizer, Esther Albertien Kleibeuker, Sarah Derks, Bianca Mostert, Hanneke van Laarhoven, Jacco Juri de Haan   +7 more
wiley   +1 more source

Engineered virus-hunter vaccine overcomes HBV immune tolerance. [PDF]

Gut
Chen X, Liu X, Xu T, Wang Y, Wang P, Liu H, Jiang Y, Qin X, Zhang L, Xiong Y, Ding J, Chen Y, Chen F, Ning W, Zeng H, Yang S, Xu L, Zhang T, Yuan Q, Liu C, Luo W, Xia N.   +21 more
europepmc   +1 more source

Immune Checkpoint Inhibitors Induce Intestinal Epithelial Injury and a Senescence‐Like Phenotype

iNew Medicine, EarlyView.
ICI treatment promotes the infiltration of activated immune cells into the intestinal mucosa. This inflammatory microenvironment is associated with significant epithelial injury, characterized by the disruption of the epithelial barrier, the depletion of specialized secretory cell lineages, and the induction of a premature senescence phenotype ...
Juan Wang, Shuang Wu, Shuangbiao Wei, Weizhen Xiang, Jianshang Huang, Lei Xiong, Hua Wang, Li Zuo   +7 more
wiley   +1 more source

Antibody levels and immune memory in children with kaposiform hemangioendothelioma treated with sirolimus after catch up vaccination. [PDF]

Hum Vaccin Immunother
Yuan J, Ding Y, Wang Z, Su L, Li K.
europepmc   +1 more source